Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Measles Market, by Type
6.1 Introduction
6.2 Red Measles
Market Estimates & Forecast, 2020 โ 2027
6.3 German Measles
Market Estimates & Forecast, 2020 โ 2027
Chapter 7. Global Measles Market, by Treatment
7.1 Introduction
7.2 Antibiotic Treatment
Market Estimates & Forecast, 2020 โ 2027
7.3 Antiviral Treatment
Market Estimates & Forecast, 2020 โ 2027
7.4 Vaccine
Market Estimates & Forecast, 2020 โ 2027
7.4.1 Mumps Measles Rubella Vaccine
7.4.2 Live (MMR-II) & Mumps Measles Rubella
7.4.3 Varicella Virus Vaccine
7.5 Others
Market Estimates & Forecast, 2020 โ 2027
Chapter 8 Global Measles Market, by End User
8.1 Introduction
8.2 Hospitals
Market Estimates & Forecast, 2020 โ 2027
8.3 Clinics
Market Estimates & Forecast, 2020 โ 2027
8.4 Others
Chapter 9. Global Measles Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Novartis AG
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Abbott
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Biomedical diagnostics
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Johnson & Johnson Services, Inc.
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Sanofi
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Merck & Co., Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Serum Institute of India Pvt. Ltd.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Pharmaceutical industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Measles Industry Synopsis, 2020 โ 2027
Table 2 Global Measles Market Estimates and Forecast, 2020 โ 2027, (USD Million)
Table 3 Global Measles Market by Region, 2020 โ 2027, (USD Million)
Table 4 Global Measles Market by Types, 2020 โ 2027, (USD Million)
Table 5 Global Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 6 Global Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 7 North America Measles Market by Types, 2020 โ 2027, (USD Million)
Table 8 North America Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 9 North America Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 10 US Market by Types, 2020 โ 2027, (USD Million)
Table 11 US Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 12 US Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 13 Canada Market by Types, 2020 โ 2027, (USD Million)
Table 14 Canada Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 15 Canada Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 10 South America Market by Types, 2020 โ 2027, (USD Million)
Table 17 South America Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 18 South America Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 19 Europe Market by Types, 2020 โ 2027, (USD Million)
Table 20 Europe Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 21 Europe Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 22 Western Europe Market by Types, 2020 โ 2027, (USD Million)
Table 23 Western Europe Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 24 Western Europe Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 25 Eastern Europe Market by Types, 2020 โ 2027, (USD Million)
Table 26 Eastern Europe Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 27 Eastern Europe Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 28 Asia Pacific Market by Types, 2020 โ 2027, (USD Million)
Table 29 Asia Pacific Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 30 Asia Pacific Measles Market by End Users, 2020 โ 2027, (USD Million)
Table 31 Middle East & Africa Market by Types, 2020 โ 2027, (USD Million)
Table 32 Middle East & Africa Measles Market by Treatment, 2020 โ 2027, (USD Million)
Table 33 Middle East & Africa Measles Market by End Users, 2020 โ 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Measles Market
Figure 3 Segmentation Market Dynamics for Global Measles Market
Figure 4 Global Measles market Share, by type 2020
Figure 5 Global Measles market Share, by Treatment 2020
Figure 6 Global Measles Market Share, by End Users, 2020
Figure 7 Global Measles Market Share, by Region, 2020
Figure 8 North America Measles Market Share, by Country, 2020
Figure 9 Europe Measles Market Share, by Country, 2020
Figure 10 Asia Pacific Measles Market Share, by Country, 2020
Figure 11 Middle East & Africa Measles Market Share, by Country, 2020
Figure 12 Global Measles Market: Company Share Analysis, 2020 (%)
Figure 13 Novartis AG: Key Financials
Figure 14 Novartis AG: Segmental Revenue
Figure 15 Novartis AG: Geographical Revenue
Figure 16 Abbott: Key Financials
Figure 17 Abbott: Segmental Revenue
Figure 18 Abbott: Geographical Revenue
Figure 19 Biomedical diagnostics: Key Financials
Figure 20 Biomedical diagnostics: Segmental Revenue
Figure 21 Biomedical diagnostics: Geographical Revenue
Figure 22 Johnson & Johnson Services, Inc.: Key Financials
Figure 23 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 24 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 25 Sanofi: Key Financials
Figure 26 Sanofi: Segmental Revenue
Figure 27 Sanofi: Geographical Revenue
Figure 28 Merck & Co., Inc.: Key Financials
Figure 29 Merck & Co., Inc.: Segmental Revenue
Figure 30 Merck & Co., Inc.: Geographical Revenue
Figure 31 Serum Institute of India Pvt. Ltd.: Key Financials
Figure 32 Serum Institute of India Pvt. Ltd.: Segmental Revenue
Figure 33 Serum Institute of India Pvt. Ltd.: Geographical Revenue